Peptron, Inc. (KOSDAQ:087010)
285,000
-1,500 (-0.52%)
At close: Feb 27, 2026
Peptron Market Cap
Peptron has a market cap or net worth of 6.65 trillion as of February 27, 2026. Its market cap has increased by 199.00% in one year.
Market Cap
6.65T
Enterprise Value
6.57T
Revenue
6.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
285,000.00
Market Cap Chart
Since July 22, 2015, Peptron's market cap has increased from 211.83B to 6.65T, an increase of 3,037.20%. That is a compound annual growth rate of 38.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 6.65T | 12.20% |
| Dec 30, 2025 | 5.92T | 149.72% |
| Dec 30, 2024 | 2.37T | 185.66% |
| Dec 28, 2023 | 830.23B | 426.14% |
| Dec 29, 2022 | 157.80B | -31.08% |
| Dec 30, 2021 | 228.96B | -8.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 21.79T |
| SK Biopharmaceuticals | 9.38T |
| LigaChem Biosciences | 6.98T |
| HLB Co., Ltd. | 6.88T |
| Voronoi | 6.02T |
| D&D Pharmatech | 4.02T |
| SK bioscience | 3.84T |
| OliX Pharmaceuticals | 3.63T |